Mauro Biffi

TL;DR: In this paper, the authors reported clinical presentation, occurrence of sudden infant death, and results of the available therapies in the largest group of patients with short QT syndrome (SQTS), studied so far, are reported.

TL;DR: Cardioverter-defibrillator capabilities was associated with a significant alleviation of CHF symptoms, increase in functional capacity, and improvement in QOL.

TL;DR: The possibility of implanting an implantable cardioverterdefibrillator in the electrophysiological laboratory, with minimal risks for patients, has meant that the implantable Cardiac Implant is considered the best therapeutic strategy in the prevention of arrhythmic death in selected patients at high risk of sudden cardiac death.

TL;DR: A simplified CRT-D device with fixed long detection reduced overall ICD therapy burden and HF hospitalizations without entailing any additional adverse events in primary prevention non-ischaemic HF patients.